|Bid||1.2400 x 800|
|Ask||1.4800 x 900|
|Day's range||1.2700 - 1.3700|
|52-week range||1.2500 - 6.6000|
|Beta (5Y monthly)||1.70|
|PE ratio (TTM)||N/A|
|Earnings date||23 Feb 2022 - 28 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||2.50|
If you want to know who really controls NantHealth, Inc. ( NASDAQ:NH ), then you'll have to look at the makeup of its...
MORRISVILLE, N.C., November 16, 2021--NantHealth, Inc. (NASDAQ: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that Maryland Physicians Care (MPC), an existing customer of the Eviti Connect for Oncology platform, selected NantHealth’s Eviti Connect for Autoimmune Diseases solution as the foundation for MPC’s new industry-leading digital drug authorization program for members living with chronic autoimmune cond
Image source: The Motley Fool. NantHealth, Inc. Common Stock (NASDAQ: NH)Q3 2021 Earnings CallNov 04, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGreetings and welcome to the NantHealth Inc.